Medigen Vaccine Biologics Corporation (6547.TWO)
TWD 41.0
(-5.86%)
TWD 41.0
(-5.86%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.24 Billion TWD | -3.13% |
| 2022 | 2.31 Billion TWD | 272.21% |
| 2021 | 622.95 Million TWD | 78.29% |
| 2020 | 349.4 Million TWD | -61.62% |
| 2019 | 910.28 Million TWD | 59.39% |
| 2018 | 571.09 Million TWD | -7.2% |
| 2017 | 615.41 Million TWD | 76.89% |
| 2016 | 347.9 Million TWD | 12.52% |
| 2015 | 309.18 Million TWD | 127.43% |
| 2014 | 135.94 Million TWD | 598.49% |
| 2013 | 19.46 Million TWD | -12.13% |
| 2012 | 22.15 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 460.54 Million TWD | -78.68% |
| 2024 Q1 | 2.16 Billion TWD | -3.81% |
| 2023 Q1 | 2.16 Billion TWD | -6.58% |
| 2023 Q3 | 2.2 Billion TWD | 2.4% |
| 2023 Q2 | 2.15 Billion TWD | -0.49% |
| 2023 Q4 | 2.24 Billion TWD | 1.77% |
| 2023 FY | 2.24 Billion TWD | -3.13% |
| 2022 Q4 | 2.31 Billion TWD | 3.6% |
| 2022 Q3 | 2.23 Billion TWD | -6.44% |
| 2022 Q2 | 2.39 Billion TWD | 278.85% |
| 2022 FY | 2.31 Billion TWD | 272.21% |
| 2022 Q1 | 631.44 Million TWD | 1.36% |
| 2021 Q2 | 1.24 Billion TWD | 180.04% |
| 2021 FY | 622.95 Million TWD | 78.29% |
| 2021 Q4 | 622.95 Million TWD | -28.68% |
| 2021 Q1 | 445.21 Million TWD | 27.42% |
| 2021 Q3 | 873.43 Million TWD | -29.95% |
| 2020 Q4 | 349.4 Million TWD | -57.39% |
| 2020 FY | 349.4 Million TWD | -61.62% |
| 2020 Q1 | 806.88 Million TWD | -11.36% |
| 2020 Q2 | 798.47 Million TWD | -1.04% |
| 2020 Q3 | 820 Million TWD | 2.7% |
| 2019 FY | 910.28 Million TWD | 59.39% |
| 2019 Q2 | 862.07 Million TWD | -0.28% |
| 2019 Q3 | 859.81 Million TWD | -0.26% |
| 2019 Q4 | 910.28 Million TWD | 5.87% |
| 2019 Q1 | 864.47 Million TWD | 51.37% |
| 2018 Q4 | 571.09 Million TWD | 3.87% |
| 2018 FY | 571.09 Million TWD | -7.2% |
| 2018 Q3 | 549.79 Million TWD | -3.52% |
| 2018 Q2 | 569.88 Million TWD | -2.79% |
| 2018 Q1 | 586.21 Million TWD | -4.74% |
| 2017 Q3 | 496.25 Million TWD | 0.83% |
| 2017 Q2 | 492.15 Million TWD | 0.0% |
| 2017 Q1 | - TWD | -100.0% |
| 2017 FY | 615.41 Million TWD | 76.89% |
| 2017 Q4 | 615.41 Million TWD | 24.01% |
| 2016 Q1 | 397.78 Million TWD | 28.66% |
| 2016 Q2 | 397.78 Million TWD | 0.0% |
| 2016 Q4 | 347.9 Million TWD | 0.0% |
| 2016 FY | 347.9 Million TWD | 12.52% |
| 2015 Q3 | 309.18 Million TWD | 88.2% |
| 2015 Q1 | 164.28 Million TWD | 20.85% |
| 2015 Q2 | 164.28 Million TWD | 0.0% |
| 2015 FY | 309.18 Million TWD | 127.43% |
| 2015 Q4 | 309.18 Million TWD | 0.0% |
| 2014 FY | 135.94 Million TWD | 598.49% |
| 2014 Q1 | - TWD | 0.0% |
| 2014 Q3 | 135.94 Million TWD | 0.0% |
| 2014 Q4 | 135.94 Million TWD | 0.0% |
| 2013 FY | 19.46 Million TWD | -12.13% |
| 2012 FY | 22.15 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | -284.942% |
| Level Biotechnology Inc. | 273.2 Million TWD | -722.13% |
| Sagittarius Life Science Corp | 137.82 Million TWD | -1529.663% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | -1037.416% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | -69.152% |
| GlycoNex Incorporation | 276.39 Million TWD | -712.618% |
| VBI | 21.25 Million TWD | -10469.23% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | -615.978% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | -336.425% |
| Visgeneer Inc. | 185.6 Million TWD | -1110.133% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | -69.744% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | -206.427% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -1773.909% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -33838.758% |
| Enimmune corporation | 173.46 Million TWD | -1194.839% |
| TaiRx, Inc. | 60.62 Million TWD | -3604.853% |
| CHO Pharma, Inc. | 110.83 Million TWD | -1926.551% |
| EirGenix Inc. | 1.14 Billion TWD | -96.147% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -1905.757% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | -338.311% |
| Lin BioScience, Inc. | 167.73 Million TWD | -1239.097% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -2296.725% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -3463.263% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | -1700.758% |
| Lukas Biomedical Inc. | 161.05 Million TWD | -1294.562% |
| RBC Bioscience Corporation | 513.08 Million TWD | -337.761% |
| BiOptic Inc. | 170.56 Million TWD | -1216.855% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -5227.736% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -9558.426% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -8276.784% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | -130.453% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -32014.198% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -10481.678% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | -509.796% |
| Neith Corporation | 17.43 Million TWD | -12783.996% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -28074.448% |
| NaviFUS Corp. | 53.4 Million TWD | -4106.039% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | -366.485% |
| Sinew Pharma Inc. | 39.71 Million TWD | -5555.605% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -3769.927% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | -516.246% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | -886.441% |
| AP Biosciences Inc | 106.65 Million TWD | -2006.017% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 36.374% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -7220.71% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | -1046.011% |
| Intech Biopharm Corporation | 1.54 Billion TWD | -45.544% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | -159.233% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -24113.745% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -3924.272% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | -864.147% |
| TCI GENE Inc. | 155.54 Million TWD | -1343.97% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -8705.343% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -4764.249% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | -583.797% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -3361.505% |
| PharmaEngine, Inc. | 91 Million TWD | -2368.043% |
| Savior Lifetec Corporation | 457.95 Million TWD | -390.454% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -1924.578% |
| OBI Pharma, Inc. | 650.44 Million TWD | -245.311% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | -474.718% |
| Acepodia, Inc. | 384.47 Million TWD | -484.195% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -2525.352% |